PRMT5 and cancer: What's more, MTAP loss results in the accumulation of methylthioadenosine (MTA), which inhibits protein arginine methyltransferase 5 (PRMT5) activity and leads to reduced basal PRMT5 methylation in MTAP‐deleted cancers [8, 9].